唐銘圻 (2010) 葉酸補充合併阿茲海默症臨床藥物Memantine對Tg2576小鼠腦部基因之調節與降低類澱粉蛋白誘發神經細胞毒性之機制。私立輔仁大學營養科學系碩士論文Agarwal R, Chhillar N, Kushwaha S, Singh NK, Tripathi CB. Role of vitamin B(12), folate, and thyroid stimulating hormone in dementia: A hospital-based study in north Indian population. Ann Indian Acad Neurol. 2010;13:257-62.
Alexeyev MF, Ledoux SP, Wilson GL. Mitochondrial DNA and aging. Clin Sci. 2004;107:355-64.
Alzheimer A. Uber eine eigenartige Erkrankung der Hirnrinde. [On a peculiar disease of the cerebral cortex]. Allgemeine Zeitschrift fuer Psychiatrie und Psychischgerichtliche Medizin. 1907;64:146-8.
Alzheimer's Association. 2010 Alzheimer's disease facts and figures. Alzheimers Dement.2010;6:158-94.
Alzheimer's Association. 2011 Alzheimer's disease facts and figures. Alzheimers Dement. 2011;7:208-44.
Anguera MC, Suh JR, Ghandour H, Nasrallah IM, Selhub J, Stover PJ. Methenyltetrahydrofolate synthetase regulates folate turnover and accumulation. J Biol Chem. 2003;278:29856-62.
Behl C, Moosmann B. Antioxidant neuroprotection in Alzheimer’s disease as preventive and therapeutic approach. Free Radic Biol Med. 2002;33: 182-91.
Billings LM, Oddo S, Green KN, McGaugh JL, LaFerla FM. Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron. 2005;45:675-88.
Brandeis R, Brandys Y, Yehuda S. The use of the Morris Water Maze in the study of memory and learning. Int J Neurosci. 1989;48:29-69
Brion JP, Passareiro H, Nunez J, Flament Durand J. Mise en evidence de la immunologique de la protein tau au lesions de degeneresescence neurofibrillaire de la maladie Alzheimer. Arch Biol (Brux). 1985;95:229-35.
Broadbent NJ, Squire LR, Clark RE. Spatial memory, recognition memory, and the hippocampus. Proc Natl Acad Sci USA. 2004;101:14515-20.
Burdick D, Soreghan B, Kwon M, Kosmoski J, Knauer M, Henschen A, Yates J, Cotman C, Glabe C. Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs. J Biol Chem. 1992;267:546-54.
Chen TF, Chiu MJ, Huang CT, Tang MC, Wang SJ, Wang CC, Huang RF. Changes in dietary folate intake differentially affect oxidised lipid and mitochondrial DNA damage in various brain regions of rats in the absence/presence of intracerebroventricularly injected amyloid β-peptide challenge. Br J Nutr. 2011;105:1294-302.
Chen TF, Huang RF, Lin SE, Lu JF, Tang MC, Chiu MJ. Folic Acid potentiates the effect of memantine on spatial learning and neuronal protection in an Alzheimer's disease transgenic model. J Alzheimers Dis. 2010;20:607-15.
Chinnery PF, Samuels DC, Elson J, Turnbull DM. Accumulation of mitochondrial DNA mutations in ageing, cancer, and mitochondrial disease: is there a common mechanism? Lancet. 2002;360:1323-5.
Clavaguera F et al. Transmission and spreading of tauopathy in transgenic mouse brain. Nat Cell Biol. 2009;11:909-13.
de Calignon A, Fox LM, Pitstick R, Carlson GA, Bacskai BJ, Spires-Jones T, Hyman BT. Caspase activation precedes and leads to tangles. Nature. 2010; 464:1201-4.
D'Hooge R and De Deyn PP. Applications of the Morris water maze in the study of learning and memory. Brain Research Reviews. 2001;36:60-90.
Dickson DW, Crystal HA, Bevona C, Honer W, Vincent I, Davies P. Correlations of synaptic and pathological markers with cognition of the elderly. Neurobiol Aging. 1995;16:285-98; discussion 298-304.
Djukic A.. Folate-Responsive Neurologic Diseases. Pediatr Neurol. 2007;37:387-97.
Duyckaerts C. Looking for the link between plaques and tangles. Neurobiol Aging. 2004;25:735-9.
Eisenga BH, Collins TD, McMartin KE.Incorporation of 3H-label from folic acid is tissue-dependent in folate-deficient rats. J Nutr. 1992 Apr;122:977-85.
Fuh JL, Wang SJ. Dementia in Taiwan: past, present, and future. Acta Neurol Taiwan. 2008;17:153-61
Fuso A, Nicolia V, Cavallaro RA, Ricceri L, D'Anselmi F, Coluccia P, Calamandrei G, Scarpaa S. B-vitamin deprivation induces hyperhomocysteinemia and brain S-adenosylhomocysteine, depletes brain S-adenosylmethionine, and enhances PS1 and BACE expression and amyloid-β deposition in mice. Mol Cell Neurosci. 2008;37:731-46.
Gamblin TC et al. Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease. Proc Natl Acad Sci USA. 2003;100:10032-7.
Garcia-Sierra F, Mondragon-Rodriguez S, Basurto-Islas G. Truncation of tau protein and its pathological significance in Alzheimer disease. J Alzheimers Dis. 2008;14:401-9.
Glenner GG, Wong CW. Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem Biophys Res Commun. 1984b;122:1131-5.
Glenner GG, Wong CW. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun. 1984a;120:885-90.
Goedert M, Spillantini MG, Jakes R, Rutherford D, Crowther RA. Multiple isoforms of human microtubuleassociated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer’s disease. Neuron. 1989;3:519-26.
GomezIsla T, Hollister R, West H, Mui S, Growdon JH, Petersen RC, Parisi JE, Hyman BT. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer’s disease. Ann Neurol. 1997;41: 17-24.
Gotz J, Chen F, van Dorpe J, Nitsch RM. Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils. Science. 2001;293:1491-5.
Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA. 1986; 83:4913-7.
Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science. 2002;297: 353-6.
Hardy JA, Higgins GA. Alzheimer's disease: the amyloid cascade hypothesis. Science. 1992;256:184-85.
Homocysteine effects on brain volumes mapped in 732 elderly individuals. Neuroreport. 2011;22:391-5.
Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F, Cole G. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science. 1996;274:99-102.
Hsu MJ, Sheu JR, Lin CH, Shen MY, Hsu CY. Mitochondrial mechanisms in amyloid beta peptide-induced cerebrovascular degeneration. Biochim Biophys Acta. 2009;1800:290-6.
Iqbal K et al. Tau pathology in Alzheimer disease and other tauopathies. Biochim Biophys Acta. 2005;1739:198-210.
Ittner LM et al. Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer disease mouse models. Cell. 2010;142:387-97.
Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina N, Ihara Y. Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43). Neuron. 1994;13:45-53.
Jarrett JT, Berger EP, Lansbury PT Jr. The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry. 1993;32:4693-7.
Kawarabayashi T, Younkin LH, Saido TC, Shoji M, Ashe KH, Younkin SG. Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer’s disease. J Neurosci. 2001;21:372-81.
Kitaguchi N, Takahashi Y, Tokushima Y, Shiojiri S, Ito H. Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity. Nature. 1988;331:530-32.
Kitamura Y, Kusuhara H, Sugiyama Y. Basolateral efflux mediated by multidrug resistance-associated protein 3 (Mrp3/Abcc3) facilitates intestinal absorption of folates in mouse. Pharm Res. 2010;27:665-72.
Kojro E, Fahrenholz F. The non-amyloidogenic pathway: structure and function of alpha-secretases. Subcell Biochem. 2005;38:105-27.
Kosik KS, Joachim CL, Selkoe DJ. Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease. Proc Natl Acad Sci USA. 1986;83:4044-8.
Lee S, Lemere CA, Frost JL, Shea TB. Dietary supplementation with S-adenosyl methionine delayed amyloid-β and tau pathology in 3xTg-AD mice. J Alzheimers Dis. 2012;28:423-31.
Lewis J et al. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science. 2001; 293:1487-91.
Liang CT, Chueh LL, Pang VF, Zhuo YX, Liang SC, Yu CK, Chiang H, Lee CC, Liu CH. A non-biotin polymerized horseradish-peroxidase method for the immunohistochemical diagnosis of canine distemper. J Comp Pathol. 2007;136:57-64.
Lipp HP, Wolfer DP. Genetically modified mice and cognition. Curr Opin Neurobiol. 1998;8:272-80.
Maruszak A, Gaweda-Walerych K, Sołtyszewski I, Zekanowski C. Mitochondrial DNA in pathogenesis of Alzheimer's and Parkinson's diseases. Acta Neurobiol Exp. 2006;66:153-76.
Mattson MP, Gleichmann M, Cheng A. Mitochondria in neuroplasticity and neurological disorders. Neuron. 2008;60:748-66.
Morris R, Mucke L. Alzheimer’s disease: a needle fromthe haystack. Nature. 2006;440:284-5.
Newman EM, Tsai JF. Microbiological analysis of 5-formyltetrahydrofolic acid and other folates using an automatic 96-well plate reader. Anal Biochem. 1986;154:509-15.
Oddo S, Vasilevko V, Caccamo A, Kitazawa M, Cribbs DH, LaFerla FM. Reduction of soluble Abeta and tau, but not soluble Abeta alone, ameliorates cognitive decline in transgenic mice with plaques and tangles. J Biol Chem. 2006;281:39413-23.
Querfurth HW, LaFerla FM. Alzheimer’s disease. N Engl J Med. 2010;362: 329-44.
Rajagopalan P, Hua X, Toga AW, Jack CR Jr, Weiner MW, Thompson PM. Ravagnan L, Roumier T, Kroemer G. Mitochondria, the killer organelles and their weapons. J Cell Physiol. 2002;192;131-7.
Reddy PH, Beal MF. Are mitochondria critical in the pathogenesis of Alzheimer’s disease? Brain Res Rev. 2005;49:618-32.
Rissman RA, Poon WW, Blurton-Jones M, Oddo S, Torp R, Vitek MP, LaFerla FM, Rohn TT, Cotman CW. Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology. J Clin Invest. 2004; 114:121-30.
Roberson ED, ScearceLevie K, Palop JJ, Yan F, Cheng IH, Wu T, Gerstein H, Yu GQ, Mucke L. Reducing endogenous tau ameliorates amyloid beta induced deficits in an Alzheimer’s disease mouse model. Science. 2007;316:50-4.
Selkoe DJ. The molecular pathology of Alzheimer's disease. Neuron. 1991;6:487-98.
Smach MA, Jacob N, Golmard JL, Charfeddine B, Lammouchi T, Ben Othman L, Dridi H, Bennamou S, Limem K. Folate and homocysteine in the cerebrospinal fluid of patients with Alzheimer's disease or dementia: a case control study. Eur Neurol. 2011;65:270-8.
Sontag E, Nunbhakdi-Craig V, Sontag JM, Diaz-Arrastia R, Ogris E, Dayal S,Lentz SR, Arning E, Bottiglieri T. Protein Phosphatase 2A Methyltransferase Links Homocysteine Metabolism with Tau and Amyloid Precursor Protein Regulation. J Neurosci. 2007;27:2751-9.
Spillantini MG, Bird TD, Ghetti B. Frontotemporal dementia and Parkinsonism linked to chromosome 17: a new group of tauopathies. Brain Pathol. 1998;8:387-402.
Squire LR. Memory and the hippocampus: a synthesis from findings with rats, monkeys, and humans. Psychol Rev. 1992;99:195-231.
Thal DR, Rüb U, Orantes M, Braak H. Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology. 2002;58:1791-800
Varela-Moreiras G, Selhub J. Long-term folate deficiency alters folate content and distribution differentially in rat tissues. J Nutr. 1992 ;122:986-91.
Vassar R et al. Beta-secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACE. Science. 1999;286:735-41.
Vassar R. beta-Secretase, APP and Abeta in Alzheimer’s disease. Subcell Biochem. 2005;38:79-103.
Velliquete RA, O’Connor T, Vassar R. Energy inhibition elevates beta-secretase levels and activity and is potentially amyloidogenic in APP transgenic mice: possible early events in Alzheimer’s disease pathogenesis. J Neurosci. 2005;25:10874-83.
Wang YP, Biernat J, Pickhardt M, Mandelkow E, Mandelkow EM. Stepwise proteolysis liberates tau fragments that nucleate the Alzheimer-like aggregation of full-length tau in a neuronal cell model. Proc Natl Acad Sci USA. 2007;104:10252-7.
Westerman MA, Cooper-Blacketer D, Mariash A, Kotilinek L, Kawarabayashi T, Younkin LH, Carlson GA, Younkin SG, Ashe KH. The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer’s disease. J Neurosci. 2002;22:1858-67.
Yin H, Kuret J. C-terminal truncation modulates both nucleation and extension phases of tau fibrillization. FEBS Lett. 2006;580:211-5.
Zhang CE, Wei W, Liu YH, Peng JH, Tian Q, Liu GP, Zhang Y, Wang JZ. Hyperhomocysteinemia Increases β-Amyloid by Enhancing Expression of γ-Secretase and Phosphorylation of Amyloid Precursor Protein in Rat Brain. Am J Pathol. 2009;174:1481-91.